A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients

The purpose of the study was to evaluate the effect of lisofylline (LSF) on engraftment, regimen-related toxicities (RRT), and mortality in patients undergoing allogeneic bone marrow transplantation (BMT). We performed a multicenter, randomized placebo-controlled trial in 60 patients with hematologi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2000-02, Vol.25 (3), p.283-291
Hauptverfasser:	LIST, A. F, MAZIARZ, R, DAHLBERG, S, KIRKHART, B, BIANCO, J. A, SINGER, J. W, STIFF, P, JANSEN, J, LIESVELD, J, ANDREWS, F, SCHUSTER, M, WOLFF, S, LITZOW, M, KARANES, C
Format:	Artikel
Sprache:	eng
Schlagworte:	Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Bone marrow Bone marrow transplantation Bone marrow, stem cells transplantation. Graft versus host reaction Conditioning Engraftment Histocompatibility antigen HLA Infections Leukocytes (neutrophilic) lisofylline Medical sciences Nausea Patients Placebos Rank tests Recovery Stem cell transplantation Survival Toxicity Transfusions. Complications. Transfusion reactions. Cell and gene therapy Transplantation Vomiting
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!